ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $41,000 | +70.8% | 197,022 | +131.2% | 0.00% | – |
| Q1 2022 | $24,000 | -87.2% | 85,210 | -74.5% | 0.00% | – |
| Q4 2021 | $187,000 | -23.0% | 334,248 | +40.1% | 0.00% | – |
| Q3 2021 | $243,000 | -88.4% | 238,532 | -84.3% | 0.00% | -100.0% |
| Q2 2021 | $2,093,000 | -1.0% | 1,516,715 | +21.9% | 0.00% | -50.0% |
| Q1 2021 | $2,114,000 | +1042.7% | 1,243,741 | +732.6% | 0.00% | – |
| Q4 2020 | $185,000 | -28.3% | 149,389 | -17.8% | 0.00% | – |
| Q3 2020 | $258,000 | +1333.3% | 181,732 | +1097.0% | 0.00% | – |
| Q1 2020 | $18,000 | -83.5% | 15,182 | -70.7% | 0.00% | – |
| Q4 2019 | $109,000 | -69.8% | 51,743 | -68.5% | 0.00% | -100.0% |
| Q3 2019 | $361,000 | +14.2% | 164,489 | +31.8% | 0.00% | – |
| Q2 2019 | $316,000 | -89.6% | 124,818 | -85.7% | 0.00% | -100.0% |
| Q1 2019 | $3,033,000 | +1807.5% | 871,409 | +1163.2% | 0.01% | – |
| Q4 2018 | $159,000 | -67.1% | 68,983 | -70.0% | 0.00% | -100.0% |
| Q1 2018 | $483,000 | -32.7% | 230,067 | -35.1% | 0.00% | 0.0% |
| Q4 2017 | $718,000 | -63.7% | 354,330 | -17.7% | 0.00% | -66.7% |
| Q3 2017 | $1,980,000 | +94.7% | 430,365 | -9.1% | 0.00% | +50.0% |
| Q2 2017 | $1,017,000 | +209.1% | 473,218 | +353.6% | 0.00% | +100.0% |
| Q1 2017 | $329,000 | -29.1% | 104,314 | -41.5% | 0.00% | 0.0% |
| Q4 2016 | $464,000 | +572.5% | 178,380 | +907.8% | 0.00% | – |
| Q3 2016 | $69,000 | -44.4% | 17,700 | -61.6% | 0.00% | – |
| Q2 2016 | $124,000 | -74.6% | 46,100 | -70.9% | 0.00% | -100.0% |
| Q1 2016 | $488,000 | -22.3% | 158,337 | -2.9% | 0.00% | 0.0% |
| Q4 2015 | $628,000 | +193.5% | 163,003 | +132.6% | 0.00% | – |
| Q3 2015 | $214,000 | -70.3% | 70,080 | -58.7% | 0.00% | -100.0% |
| Q2 2015 | $720,000 | +217.2% | 169,828 | +402.4% | 0.00% | – |
| Q4 2014 | $227,000 | -76.5% | 33,800 | -64.2% | 0.00% | -100.0% |
| Q2 2014 | $967,000 | -53.4% | 94,321 | -51.0% | 0.00% | -57.1% |
| Q3 2013 | $2,075,000 | +888.1% | 192,500 | +749.5% | 0.01% | +600.0% |
| Q2 2013 | $210,000 | – | 22,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |